Mavyret - Information on Prescription Medication for Chronic Hepatitis C
Mavyret FAQ
What is Mavyret used for?
Mavyret is a brand-name prescription drug that’s used to treat chronic (long-term) hepatitis C virus (HCV). This virus infects your liver and causes inflammation. Mavyret can be used by people with any of the six types of HCV who either don’t have cirrhosis (liver scarring) or who have compensated (mild) cirrhosis.
Does Mavyret contain glecaprevir and pibrentasvir?
Mavyret contains a combination of glecaprevir and pibrentasvir. Glecaprevir and pibrentasvir are antiviral medications that prevent hepatitis C virus (HCV) from multiplying in your body. Mavyret is used to treat chronic hepatitis C in people with HCV genotype 1, 2, 3, 4, 5, or 6.
Is Mavyret safe for children?
Mavyret contains the two medicines: glecaprevir and pibrentasvir. It is not known if Mavyret is safe and effective in children under 12 years of age. What is the most important information I should know about Mavyret? Mavyret can cause serious side effects, including: Hepatitis B virus reactivation.
Does Mavyret treat hepatitis C?
Mavyret is an antiviral combination agent that is approved to treat all six genotypes (1-6) of hepatitis C virus (HCV) in adults and children aged 12 years of age and older.
What is Mavyret?
Mavyret is an antiviral prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of chronic hepatitis C virus infection (HCV) in adults and children 3 years of age and older who meet certain requirements, as determined by a health care provider.
How does Mavyret work?
Mavyret is prescribed for use in adults and children ages 3 years and older. The drug works to cure HCV by stopping the virus from multiplying (making more of itself). HCV is considered cured when the virus can no longer be seen on certain blood tests. There are several genotypes (strains) of long lasting HCV.
Who should take Mavyret?
With today’s approval, dosing information is provided for Mavyret for the treatment of adult or pediatric patients 12 years and older, or weighing at least 99 pounds, who are infected with any of six identified HCV genotypes either without cirrhosis or with compensated cirrhosis.
Mavyret References
If you want to know more about Mavyret, consider exploring links below:
What Is Mavyret
- https://www.drugs.com/mavyret.html
- https://www.healthline.com/health/drugs/mavyret
- https://www.mavyret.com/
- https://www.medicalnewstoday.com/articles/mavyret
- https://www.healthdirect.gov.au/medicines/brand/amt,1106161000168101/maviret
- https://en.wikipedia.org/wiki/Glecaprevir/pibrentasvir
- https://www.medicine.com/drug/mavyret